Dataset: Hypothesis: Intranasal delivery of Spermidine-modified Ginseng Extracellular Vesicles (S-GEVs) loaded with GRN mRNA exploits the cribriform plate anatomy to bypass the blood-brain barrier, providing a neuro-targeted delivery system for progranulin gene therapy that acts synergistically with spermidine-induced autophagy to suppress pathological TMEM106B amyloid accumulation and restore endolysosomal homeostasis. - PathMap Experiment #000123

Interactive Data Viewer: Read, View, and Print from Day 1 Use our fully interactive viewer to view, read, and print this research data right from Day 1: https://pathmap.org/viewer.php?id=123 Artificial General Intelligence LLC Claim Evaluated: Hypothesis: Intranasal delivery of Spermidine-modified Ginseng Extracellular Vesicles (S-GEVs) loaded with GRN mRNA exploits the cribriform plate anatomy to bypass the blood-brain barrier, providing a neuro-targeted delivery system for progranulin gene therapy that acts synergistically with spermidine-induced autophagy to suppress pathological TMEM106B amyloid accumulation and restore endolysosomal homeostasis. This dataset contains the raw JSON execution trace, verified verbatim quotes, and MeSH-aligned logic gates generated by PathMap Studio's Veridical Enforcement engine. 🔍 Novel & Overlooked Insights TMEM106B aggregation is not merely a loss-of-function event but involves the formation of universal intracellular amyloid filaments across multiple neurodegenerative diseases. Nasal delivery routes, specifically through arachnoid fenestrations at the olfactory bulb, are increasingly recognized as viable channels for protein and nucleic acid transport. Ginseng-derived exosomes are effectively serving as "natural nanocarriers" capable of cross-kingdom delivery of metabolites and therapeutics. Spermidine's efficacy as a neuroprotector is dosage-dependent, where "low doses has the potential to be a general-purpose neuroprotector." Autophagic flux, regulated by proteins such as Beclin-1 and the mTOR/AMPK axis, is a critical regulatory node for both progranulin and TMEM106B-associated pathologies. The TMEM106B/progranulin endolysosomal-lipid axis is essential for metabolic homeostasis; its disruption leads to protein accumulation. Emerging "Gasotransmitter Trio Networks" (NO, CO, H2S) modulate autophagy and mitophagy alongside the protein-based pathways of *GRN* and TMEM106B. Recent proteomics studies confirm that CLK4 regulates autophagy-related proteins (e.g., SQSTM1) in cancer and degenerative models, highlighting broader splicing/autophagy interactions. 🧪 Extracted Custom Datapoints 📊 Suggested Experiments Test the brain-targeting efficiency of intranasal S-GEVs versus non-modified GEVs in a mouse model using fluorescence imaging. Evaluate the stability and protein expression of GRN mRNA delivered via S-GEVs in a PGRN-deficient SH-SY5Y neuronal cell line. Assess the reduction of TMEM106B amyloid aggregation in hippocampal tissues of a PGRN-deficient/TMEM106B-overexpressing transgenic mouse model treated with S-GEVs-GRN mRNA. 📊 Suggested Studies Pharmacokinetic and biodistribution profiling of S-GEVs via the intranasal route in aging vs. young mice. A study investigating the dose-response relationship between spermidine-mediated GEV surface modification and lysosomal acidification in microglia. Comparative analysis of GRN mRNA encapsulation efficiency across different GEV sources (ginseng vs. other plant-derived exosomes). 📊 Swansons Literature Based Discovery Candidates Spermidine-induced autophagy regulation via TFEB-dependent pathways may directly facilitate the degradation of TMEM106B amyloid filaments in lysosomal storage disorders. Spermidine and autophagy in aging and neurodegeneration (e.g., ID 42012729, ID 42541426) TMEM106B protein aggregation and amyloid filaments in neurodegenerative disease (e.g., ID 37563705) TFEB (Transcription Factor EB), which regulates both lysosomal biogenesis and autophagic flux, activated by spermidine and impaired in TMEM106B/progranulin models. Spermidine is a known inducer of autophagy through EP300 inhibition and TFEB activation. Since TMEM106B amyloid filaments induce lysosomal dysfunction, TFEB-driven restoration of lysosomal capacity would logically prevent the accumulation of these filaments. 📊 Contradictions Between Evidences Conflicting roles of autophagy in ischemic stroke are noted: moderate activation is neuroprotective, while excessive autophagy leads to cell death (ID 42548587), which parallels the 'Goldilocks' requirement for autophagy induction in neuroprotection. 📊 Repurposed Solutions Exosome-mediated delivery of growth factors or siRNA (e.g., VEGF/NGF, IL-6 siRNA) as established platforms for neuro-targeted therapy (ID 42530044, ID 41491215). Tags Attractor Table Extracted Keywords & Entities Administration, Intranasal, _gates_from_administration,_intranasal, Olfactory Bulb, _gates_to_olfactory_bulb, Progranulins, _gates_from_progranulins, _gates_to_progranulins, RNA, Messenger, _gates_from_rna,_messenger, PGRN protein, _gates_to_pgrn_protein, Autophagy, _gates_from_autophagy, TMEM106B Protein, _gates_to_tmem106b_protein Run Your Own Analysis PathMap is a patent-pending universal AI workbench designed to eliminate LLM hallucinations in medical research. Generate your own autonomous discovery reports at PathMap.org.